#YonhapInfomax #ChongKunDang #DrugPriceCuts #DomesticManufacturing #PharmaceuticalIndustry #RDInvestment #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=102001

Chong Kun Dang CEO Kim Young-joo Warns Drug Price Cuts Could Force Abandonment of Domestic Manufacturing
Chong Kun Dang CEO Kim Young-joo warned that further drug price cuts could force South Korea's pharmaceutical industry to abandon domestic manufacturing, citing rising costs and declining profitability, while urging policy reforms to protect innovation and R&D investment.
